[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019

Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Registered in



:: Volume 24, Issue 6 (2-2017) ::
Journal of Ilam University of Medical Sciences 2017, 24(6): 33-40 Back to browse issues page
The Analysis of HDAC1 Gene Expression Alteration in Patients with Prostate Cancer
Nadia Mirzaei1 , Fatemeh Shakarami1 , Farzam Ajamian * 2, Ali Hamidi madani3 , Mohammad mehdi Sohani1
1- Dept of Biology, Faculty of Sciences, Guilan University, Rasht, Iran
2- Dept of Biology, Faculty of Sciences, Guilan University, Rasht, Iran , ajamian@guilan.ac.ir
3- Dept of Urology, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Abstract:   (9129 Views)

Introduction: Chromatin Epigenetic changes have a key role in pathophysiology of prostate cancer. The most important epigenetic changes are change in DNA methylation, histones modifications, changes in chromatin status and micro RNAs regulatory patterns which are related to tumor creation. Histone deacetylases (HDACs) comprise a large family of enzymes which act as key regulators of nucleosomal histone consistency. HDACs have a great role to start and develop prostate cancer which is due to changes they create. Epigenetic modifications, in particular DNA hypermethylation and histone acetylation have an essential role in the regulation of genes that protect against prostate cancer. Since epigenetic changes are reversible, they are interesting targets for cancer therapy. Many epi-drugs such as histone deacetylase inhibitors (HDACi) show anti-cancer properties in either cell culture or in the animal models of prostate cancer.

 Materials & methods: In this case-control study, RNA extraction was performed on samples then the expression of HDAC1 in human prostate cancer using reverse-transcription polymerase chain reaction (RT-PCR). This study was conducted comparing 20 patients diagnosed with prostate cancer to 20 disease free control subjects.

Findings: Our findings suggest that the expression of HDAC1 mRNA is tangible and a significant difference was observed between patients and control subjects.

Discussion & conclusions: These results imply that HDAC1 mRNA expression could have potential as a marker and may have prognostic implications for Prostate cancer progression.

Keywords: Epigenetics, Histones modifica-tions, Gene expression, Histonedeacetylase (HDAC), Histone deacetylase Inhibitor (HDACi), Prostate cancer
Full-Text [PDF 617 kb]   (6043 Downloads)    
Type of Study: Research | Subject: Molecular Genetics
Received: 2015/06/26 | Accepted: 2016/01/5 | Published: 2017/02/11
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mirzaei N, Shakarami F, Ajamian F, Hamidi madani A, Sohani M M. The Analysis of HDAC1 Gene Expression Alteration in Patients with Prostate Cancer. J. Ilam Uni. Med. Sci. 2017; 24 (6) :33-40
URL: http://sjimu.medilam.ac.ir/article-1-2845-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 6 (2-2017) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.16 seconds with 41 queries by YEKTAWEB 4646